Huh Hoyoung bought AKTX
October 5, 2026 · Form 4 insider transaction
Huh Hoyoung bought 6,160 shares of Akari Therapeutics, Plc at $7.90 per share, a transaction worth $48.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 11 days after the transaction.
Footnotes
These ADSs represent RSUs, with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. This RSU grant was approved by the Board of Directors of the Issuer on October 5, 2026, and is subject to forfeiture if Shareholder Approval is not obtained. The RSUs will vest in full on the date of Shareholder Approval.; This award of RSUs was granted in lieu of accrued but unpaid cash retainers payable to non-execute directors in accordance with the Issuer's remuneration policy.